A.-L. Hulting

423 total citations
14 papers, 329 citations indexed

About

A.-L. Hulting is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, A.-L. Hulting has authored 14 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in A.-L. Hulting's work include Pituitary Gland Disorders and Treatments (11 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Adrenal and Paraganglionic Tumors (5 papers). A.-L. Hulting is often cited by papers focused on Pituitary Gland Disorders and Treatments (11 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Adrenal and Paraganglionic Tumors (5 papers). A.-L. Hulting collaborates with scholars based in Sweden and Australia. A.-L. Hulting's co-authors include Sigbritt Werner, Tomas Hökfelt, Kazuhiko Tatemoto, V. Mutt, Lars Terenius, K J Chang, Jan Fahrenkrug, Kristina Melkersson, Carin Muhr and P. O. Lundberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Internal Medicine and European Journal of Endocrinology.

In The Last Decade

A.-L. Hulting

14 papers receiving 315 citations

Peers

Countries citing papers authored by A.-L. Hulting

Since Specialization

Citations

This map shows the geographic impact of A.-L. Hulting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.-L. Hulting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.-L. Hulting more than expected).

Fields of papers citing papers by A.-L. Hulting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.-L. Hulting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.-L. Hulting. The network helps show where A.-L. Hulting may publish in the future.

Co-authorship network of co-authors of A.-L. Hulting

This figure shows the co-authorship network connecting the top 25 collaborators of A.-L. Hulting. A scholar is included among the top collaborators of A.-L. Hulting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.-L. Hulting. A.-L. Hulting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Lymphocytic hypophysitis: Report of two biopsy-proven cases and one suspected case with pituitary autoantibodies 2007 ·Journal of Endocrinological Investigation ·Sophie Bensing, A.-L. Hulting, Anders Höög, K. Ericson, Olle Kämpe	34
2	No Evidence for Autoimmunity as a Major Cause of the Empty Sella Syndrome 2004 ·Experimental and Clinical Endocrinology & Diabetes ·Sophie Bensing, Fredrik Rorsman, Patricia Crock, Carani B. Sanjeevi, K. Ericson, Olle Kämpe, Kerstin Brismar, A.-L. Hulting	18
3	Autoantibodies against alfa-MSH, ACTH and LHRH in anorexia and bulimia nervosa patients : Proceedings of the National Academy of Sciences USA 2002 ·Sergueı̈ O. Fetissov, J. Hallman, L. Oreland, Britt af Klinteberg, Eva Grenbäck, A.-L. Hulting, T Hökfelt	1
4	[Antipsychotic drugs can affect hormone balance. Weight gain, blood lipid disturbances and diabetes are important]. 2001 ·PubMed ·Kristina Melkersson, A.-L. Hulting	3
5	Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder 2000 ·European Archives of Psychiatry and Clinical Neuroscience ·Kristina Melkersson, A.-L. Hulting	23
6	Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment 1993 ·European Journal of Endocrinology ·Ove Törring, Bengt Isberg, Hans Sjöberg, Elisabet Bucht, A.-L. Hulting	19
7	Thyrotropin‐releasing hormone increases serum levels of growth hormone‐releasing hormone and growth hormone in patients with acromegaly 1992 ·Journal of Internal Medicine ·A.-L. Hulting, Elvar Theodorsson, Sigbritt Werner	4
8	Production of a galanin‐like peptide by a human pituitary adenoma: immunohistochemicaI evidence 1989 ·Acta Physiologica Scandinavica ·A.-L. Hulting, Björn Meister, (unknown), Jan Wersäll, A. Änggård, Tomas Hökfelt	19
9	DNA evaluation in growth hormone producing pituitary adenomas: flow cytometry versus single cell analysis 1989 ·European Journal of Endocrinology ·A.-L. Hulting, U Askensten, B. Tribukait, Jan Wersäll, Gert Auer, Lars Grimelius, Sture Falkmer, Sigbritt Werner	5
10	Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly 1985 ·European Journal of Endocrinology ·A.-L. Hulting, Jan Wersäll, Sigbritt Werner	2
11	Prolactinomas in Men: Clinical Characteristics and the Effect of Bromocriptine Treatment 1985 ·Acta Medica Scandinavica ·A.-L. Hulting, Carin Muhr, P. O. Lundberg, (unknown)	38
12	Somatomedin A increments are diminished in acromegaly with concomitant hyperprolactinaemia 1984 ·European Journal of Endocrinology ·A.-L. Hulting, Kathryn T. Hall, Sigbritt Werner	8
13	The PHI (PHI-27)/corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion. 1983 ·Proceedings of the National Academy of Sciences ·Tomas Hökfelt, Jan Fahrenkrug, Kazuhiko Tatemoto, V. Mutt, Sigbritt Werner, A.-L. Hulting, Lars Terenius, K J Chang	144
14	Oral contraceptive steroids do not promote the development or growth of prolactinomas 1983 ·Contraception ·A.-L. Hulting, Sigbritt Werner, Kerstin Hagenfeldt	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact